UC San Diego researchers developed an AI tool that accurately predicts colorectal cancer risk in ulcerative colitis patients using clinical and imaging data.
Key Details
- 1AI workflow reviewed records of 55,000 patients in the VA health care system, the largest US dataset of its kind.
- 2Combined large language models and statistical risk models to predict progression from low-grade dysplasia to cancer.
- 3Classified patients into five risk groups based on lesion size, number, visibility, resection completeness, and inflammation severity.
- 4Nearly half of patients were categorized as lowest risk, with the model correctly predicting 99% would not develop cancer within two years.
- 5The tool matched real-world outcomes for over ten years of follow-up data.
- 6The model may allow some low-risk patients to have less frequent surveillance colonoscopies.
Why It Matters
This AI system offers more precise, data-driven cancer risk assessments for clinicians, potentially reducing unnecessary procedures and focusing attention on high-risk patients, improving both care quality and resource allocation in gastrointestinal oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.